MedTrace Logo

The Practical Effect of Neupro

NCT04957420 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2021-07-12

No results posted yet for this study

Summary

This is a multicenter, prospective, non intervention post marketing surveillance study conducted in Chinese mainland. The main objective was to evaluate the safety characteristics of rotigotine patch in the treatment of Chinese adult patients with idiopathic Parkinson's disease in real world clinical practice.

Conditions

Interventions

DRUG

Neupro

Rotigotine Patches

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2021-12-31
Completion
2022-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04957420 on ClinicalTrials.gov